Helicobacter pylori infection relapse after eradication is not a problem in developed countries: Commentary

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 3, Issue 9, 2006, Pages 484-485

  Mégraud, Francis ^a,b   Lamouliatte, Herve ^c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b HÔPITAL PELLEGRIN   (France)

^c HÔPITAL SAINT ANDRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; TETRACYCLINE; UREA;

AGE; CIGARETTE SMOKING; CLINICAL TRIAL; COMORBIDITY; DEVELOPED COUNTRY; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; DYSPEPSIA; ENDOSCOPY; FREQUENCY ANALYSIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; INFECTION CONTROL; METHODOLOGY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PEPTIC ULCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; RELAPSE; SHORT SURVEY; TREATMENT FAILURE; UREA BREATH TEST;

EID: 33748320727     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep0600     Document Type: Short Survey

References (2)

1. Broutet N et al. (2003) Risk factors for failure of Helicobacter pylori therapy - results of an individual data analysis of 2751 patients. Aliment Pharmacol Ther 17: 99-109
2. Prouzet-Mauléon V et al. (2005) Pathogen evolution in vivo: Genome dynamics of two isolates obtained 9 years apart from a duodenal ulcer patient infected with a single Helicobacter pylori strain. J Clin Microbiol 43: 4237-4241